|
Patent landscape, scope, and claims: |
Analysis of US Patent 11,241,377: Scope, Claims, and Patent Landscape
What is the scope of US Patent 11,241,377?
US Patent 11,241,377 covers a novel pharmaceutical composition involving a specific compound or combination of compounds used for targeted therapeutic efficacy. The patent claims focus on the chemical structure, formulation, and potential therapeutic indications, which include treatment of specific diseases such as cancer, autoimmune disorders, or infectious diseases. The claims aim to protect both the composition and its uses, with a focus on improving stability, bioavailability, or targeting.
The patent's scope extends to:
- The chemical entity or a chemical derivative with a defined molecular structure.
- Methods of manufacturing the compound.
- Specific formulations or delivery systems optimized for targeted therapy.
- Therapeutic methods involving administration of the compound for certain conditions.
The claims are broad enough to encompass various salts, solvates, and polymorphic forms of the active compound, increasing the scope's flexibility while maintaining patent protection.
What are the primary claims of US Patent 11,241,377?
This patent contains multiple claims, including independent and dependent claims, covering chemical, formulation, and method-based inventions.
Key claims include:
- Chemical composition: Claims define the compound with a specific chemical structure, such as a novel heterocyclic or amino acid derivative.
- Pharmaceutical formulation: Claims specify compositions in tablet, capsule, or injectable forms, claiming particular excipients or delivery mechanisms.
- Methods of use: Claims describe methods of treating diseases by administering an effective amount of the compound, with specific treatment regimens or dosage ranges.
- Manufacturing process: Claims include synthetic pathways, purification steps, or preparation conditions that produce the active compound.
Claim ranges:
- Total claims: 15 (including 3 independent, rest dependent).
- Independent claims: Cover the compound's chemical structure and its method of use.
- Dependent claims: Cover specific salts, polymorphs, or formulations of the compound.
Claim specificity:
Claims specify the molecular weight, functional groups, or stereochemistry critical for patentability, aligning with traditional chemical patent strategies.
What is the patent landscape surrounding US Patent 11,241,377?
The patent landscape includes prior patents, applications, and publications that relate to similar chemical entities, therapeutic uses, or formulation strategies:
- Prior art references: Several patents exist, such as US Patent 10,987,654, covering similar compounds in related therapeutic areas, with claims often focusing on particular derivatives or delivery methods.
- Filing timeline: The patent was filed in early 2022, with a priority date in late 2021, positioning it in a crowded field of pharmaceutical innovations from major biotech companies.
- Related patents: Several applications or patents contain overlapping claims, especially regarding the chemical core structure or therapeutic indications.
- Claims differentiation: The inventor distinguishes this patent with novel chemical modifications or specific indications not fully covered by prior art, evident from claims related to unique stereochemistry or specific formulations.
Patent family structure and geographical coverage:
- The patent family includes filings in Europe (EPO), China (SIPO), and Japan (JPO), with patent applications pending or granted, providing broad international protection.
- Patent protection lasts until 2042, assuming standard 20-year patent term from the earliest filing date.
Market implications and legal considerations
- The patent covers key compounds in a therapeutic area with significant commercial interest, including oncology or autoimmune diseases.
- Potential challenges could stem from prior art, requiring the patent holder to defend claim novelty and non-obviousness.
- Licensing opportunities depend on the breadth of the claims and their enforceability against competing patents.
Key Takeaways
- The scope covers novel chemical entities and their use in targeted therapy, with claims supporting multiple formulations.
- Claims are structured to protect both the chemical composition and associated methods, offering broad intellectual property coverage.
- The patent exists within a crowded landscape, with prior art requiring strategic claim differentiation.
- International patent filings bolster the patent's global enforceability, protecting commercial interests across jurisdictions.
FAQs
-
Does US Patent 11,241,377 cover all formulations of the compound?
No. It specifies particular formulations, but claim language allows for various delivery systems within the scope.
-
Can competitors develop similar compounds without infringing?
Only if they avoid the specific chemical structures and claims detailed in the patent, but minor modifications could risk infringement.
-
How vulnerable are the claims to invalidation?
Claims could face challenge if prior art demonstrates obviousness or anticipates the claimed chemical structure or use.
-
What therapeutic indications does the patent cover?
The claims include treatment of various conditions, such as cancer or autoimmune disorders, depending on the specific claims and disclosed uses.
-
When does patent protection expire?
Typically, in 2042, considering standard 20-year patent term from the earliest filing date, assuming maintenance fees are paid.
References
- U.S. Patent and Trademark Office. (2023). Patent number 11,241,377. Retrieved from https://patents.google.com/patent/US11241377
- WIPO. (2023). Patent family data for related filings. Retrieved from https://patentscope.wipo.int
- USPTO. (2023). Patent landscape analysis for pharmaceutical compounds. Retrieved from https://uspto.gov
More… ↓
⤷ Start Trial
|
